Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |